Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR- mutated non-small-cell lung cancer von Cheema, P K, Gomes, M, Banerji, S, Joubert, P, Leighl, N B, Melosky, B, Sheffield, B S, Stockley, T, Ionescu, D N

Volltext

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer von Davidson, J.A, Cromwell, I, Ellard, S.L, Lohrisch, C, Gelmon, K.A, Shenkier, T, Villa, D, Lim, H, Sun, S, Taylor, S, Taylor, M, Czerkawski, B, Hayes, M, Ionescu, D.N, Yoshizawa, C, Chao, C, Peacock, S, Chia, S.K

Volltext

EP.06B.05 Ultra-Stat Idylla EGFR Testing for Non-Small Cell Lung Carcinomas: Patient Selection and Impact on Clinical Outcomes von Fitzsimmons, K.F., Hughesman, C., D'Amours, M.-F., Alex, D., Ionescu, D.N., Melosky, B., McNeil, K., Ho, C., Yip, S., Naso, J.

Volltext

Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective von Ionescu, D N, Downes, M R, Christofides, A, Tsao, M S

Volltext

Standardizing biomarker testing for Canadian patients with advanced lung cancer von Melosky, B, Blais, N, Cheema, P, Couture, C, Juergens, R, Kamel-Reid, S, Tsao, M-S, Wheatley-Price, P, Xu, Z, Ionescu, D N

Volltext

Impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines... von Ionescu, D N

Volltext

Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified von Ho, C, Tong, K M, Ramsden, K, Ionescu, D N, Laskin, J

Volltext

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective von Bebb, D G, Agulnik, J, Albadine, R, Banerji, S, Bigras, G, Butts, C, Couture, C, Cutz, J C, Desmeules, P, Ionescu, D N, Leighl, N B, Melosky, B, Morzycki, W, Rashid-Kolvear, F, Lab, Clin, Sekhon, H S, Smith, A C, Stockley, T L, Torlakovic, E, Xu, Z, Tsao, M S

Volltext

Canadian perspectives: update on inhibition of ALK -positive tumours in advanced non-small-cell lung cancer von Melosky, B, Cheema, P, Agulnik, J, Albadine, R, Bebb, D G, Blais, N, Burkes, R, Butts, C, Card, P B, Chan, A M Y, Hirsh, V, Ionescu, D N, Juergens, R, Morzycki, W, Poonja, Z, Sangha, R, Tehfe, M, Tsao, M S, Vincent, M, Xu, Z, Liu, G

Volltext

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer von Melosky, B, Agulnik, J, Albadine, R, Banerji, S, Bebb, D G, Bethune, D, Blais, N, Butts, C, Cheema, P, Cheung, P, Cohen, V, Deschenes, J, Ionescu, D N, Juergens, R, Kamel-Reid, S, Laurie, S A, Liu, G, Morzycki, W, Tsao, M S, Xu, Z, Hirsh, V

Volltext

Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer von Sheffield, B S, Bosdet, I E, Ali, R H, Young, S S, McNeil, B K, Wong, C, Dastur, K, Karsan, A, Ionescu, D N

Volltext

C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody von Ionescu, D.N., Girnita, A.L., Zeevi, A., Duquesnoy, R., Pilewski, J., Johnson, B., Studer, S., McCurry, K.R., Yousem, S.A.

Volltext

EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer von Kamel-Reid, S, Chong, G, Ionescu, D N, Magliocco, A M, Spatz, A, Tsao, M, Weng, X, Young, S, Zhang, T, Soulieres, D

Volltext

Subendothelial C4d deposition and intragraft B cell infiltrates are associated with high-grade acute rejection in lung transplantation von Girnita, A.L., Ionescu, D.N., Yousem, S.A., Zaldonis, D., McCurry, K.R., Zeevi, A.

Volltext

EP14.03: Taussing‐Bing heart von Herghelegiu, C.G., Herghelegiu, D., Oprescu, D.N., Ionescu, C., Suciu, N.

Volltext

272. Immunohistochemistry as a measurement tool for various aspects of the tumour response to radiotherapy in rectal cancer von Ionescu, S, Bratucu, E, Straja, D.N, Simion, L, Alecu, M, Prunoiu, V, Marincas, M, Cirimbei, C, Zurac, S, Staniceanu, F

Volltext